Systematic Prostate Biopsy Versus Perilesional Sampling: If It Isn't Broke, Why Fix It?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 39043548.
- Also identified by DOI 10.1016/j.eururo.2024.07.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for prostate cancer recommend a targeted and perilesional biopsy (TPLBx) strategy for primary diagnosis. In comparison to the classical approach of combined targeted and systematic biopsy, TPLBx may reduce overdiagnosis of insignificant cancers and mitigate the grade shift associated with targeted biopsy.
Medical subject headings
- Prostatic Neoplasms
- Prostate